期刊文献+

HIFU消融脾脏治疗脾功能亢进的动物实验研究 被引量:5

Animal experimental study on HIFU ablation of spleen for the treatment of hypersplenism
下载PDF
导出
摘要 目的:探讨高强度聚焦超声(HIFU)消融脾脏治疗脾功能亢进的可行性和有效性.方法:15只健康成年杂种犬随机分为对照组(A)、脾静脉结扎(SVL)组(B)和SVL+HIFU治疗组(C).SVL术后3wk对C组犬开腹行HIFU脾脏消融.观察3组犬外周血像、脾脏体积、消融后并发症及脾脏病理学变化.结果:结扎脾静脉主干及主要分支,可形成犬淤血性脾肿大、脾亢.HIFU消融区域可见凝固性坏死,血管闭塞,血栓形成.坏死能逐渐吸收、纤维化或包裹机化.无脾脓肿、脾破裂等并发症出现.消融后脾脏体积明显缩小,外周血红细胞、血小板逐渐恢复正常.结论:HIFU消融脾脏治疗实验性脾肿大和脾亢是可行和有效的,该技术可以作为临床脾亢治疗的新尝试. AIM: To investigate the feasibility and effectiveness of HIFU ablation of spleen for the treatment of hypersplenism. METHODS : Fifteen healthy mongrel dogs were randomly divided into control group (group A), splenic vein ligation (SVL) group (group B), and SVL + HIFU treatment group (group C). Dogs in group C underwent splenic ablation with HIFU under direct vision via laparotomy 3 weeks after SVL. The peripheral blood cell counts, size of spleen, complications and histopathological changes were measured regularly. RESULTS: Thrombocytopenia, erythropenia and splenomegaly were presented in the dogs with SVL. Coagulative necrosis, vascular occlusion, thrombosis of spleen were demonstrated under induction of HIFU irradiation. Lesion was gradually absorbed and fibrosed or encapsulated. No major complications including abscess or rupture of spleen occurred. The size of spleen in group C was obviously smaller than that before therapy. The counts of PLT and RBC in group C increased gradually after therapy. CONCLUSION: HIFU is feasible and effective for experimental splenomegaly and hypersplenism. This method holds promise for future clinical applications in therapy of hypersplenism.
出处 《第四军医大学学报》 北大核心 2008年第5期414-417,共4页 Journal of the Fourth Military Medical University
关键词 高强度聚焦超声 脾功能亢进 病理学 high intensity focused ultrasound dog hypersplenism pathology
  • 相关文献

参考文献4

二级参考文献19

  • 1刘经权,陈希炜,陈维佩,侯会池,叶明福.脾肿大形态结构与吞噬功能关系的实验研究[J].肝胆外科杂志,1994,2(1):9-12. 被引量:2
  • 2[1]Liu DC, Meyers MO, Hill CB, Loe WA, Jr. Laparoscopic splenectomy in children with hematological disorders:preliminary experience at the Children's Hospital of New Orleans. Am Surg 2000; 66:1168-1170
  • 3[2]Sugawara Y, Yamamoto J, Shimada K, Yamasaki S, Kosuge T, Takayama T. Splenectomy in patients with hepatocellular carcinoma and hypersplenism. J Am Coll Surg 2000;1904:446-450
  • 4[3]Shimada M, Hashizume M, Shirabe K, Takenaka K,Sugimachi K. A new surgical strategy for cirrhotic patients with hepatocellular carcinoma and hypersplenism. Performing a hepatectomy after a laparoscopic splenectomy.Surg Endosc 2000; 14:127-130
  • 5[4]Sakai T, Shiraki K, Inoue H, Sugimoto K, Ohrnori S,Murata K. Complications of partial splenic embolization in cirrhotic patients. Dig Dis Sci 2002; 47:388-391
  • 6[5]Obatake M, Muraji T, Kanegawa K, Satoh S, Nishijima E,Tsugawa C. A new volumetric evaluation of partial splenic embolization for hypersplenism in biliary atresia. J Pediatr Surg 2001; 36:1615-1616
  • 7[6]Meral A, Sevinir B, Sadikoglu Y, Nacarkucuk E, Gunay U.Partial splenic embolization in beta-thalassemia major. A case report. Turk J Pediatr 2000; 42:76-79
  • 8[7]Watanabe Y, Todani T, Noda T. Changes in splenic volume after partial splenic embolization in children. J Pediatr Surg 1996; 31:241-244
  • 9[8]Sakata K, Hirai K, Tanikawa K. A long-term investigation of transcatheter splenic arterial embolization for hypersplenism. Hepatogastroenterology 1996; 43:309-318
  • 10[9]Noguchi H, Hirai K, Aoki Y, Sakata K, Tanikawa K.Changes in platelet kinetics after a partial splenic arterial embolization in cirrhotic patients with hypersplenism.Hepatology 1995; 22:1682-1688

共引文献57

同被引文献41

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部